マーケットレポート詳細
医薬品容器包装の世界市場：2027年に至るタイプ別、送達法別予測
Pharmaceutical Packaging Market by Raw Material (Plastics, Paper & paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled syringes), Drug Delivery, and Region - Global Forecast to 2027
- 出版元：MarketsandMarkets
出版元について - 発行年：2022年1月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文315ページになります。
- 商品コード：MAM3157
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
医薬品容器包装の世界市場規模は2021年で999億ドル、2027年に2299億ドル、市場の平均年成長率は14.9%に到達する見込みです。
レポートは医薬品容器包装の世界市場について2027年までの市場予測データ(金額US$、量ベースKiloton)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（原材料別市場、タイプ別市場、等）を中心に構成されています。また競合状況、主要企業情報（11社）、市場ダイナミクス、ファイブフォース分析などの分析も加味し、医薬品容器包装市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆医薬品容器包装の世界市場予測2018-2027年
・市場規模(US$)
・量ベース(Kiloton)
◆原材料別、市場-2027年
・プラスチック
・紙/板紙
・ガラス
・金属
・その他
※(市場規模US$)(量ベースKiloton)
◆タイプ別、市場-2027年
・プラスチックボトル
・ブリスターパック
・ラベル/付属品
・キャップ/クロージャー
・医療用特殊バッグ
・プレフィルドシリンジ
・温度管理用容器包装
・パウチ/ストリップパック
・アンプル
・バイアル
・プレフィルド型吸入器
・投薬チューブ
・ジャー/キャニスター
・カートリッジ
・その他
※(市場規模US$)
◆薬物送達手段別、市場-2027年
・経口薬物送達用
・注射剤送達用
・外用剤送達用
・経眼薬物送達用
・経鼻薬物送達用
・経肺薬物送達用
・経皮薬物送達用
・静脈注射剤送達用
・その他薬物送達用
※(市場規模US$)
◆主要国地域別市場-2027年
北米
・米国、カナダ、メキシコ
欧州
・ドイツ、フランス、イタリア
・英国、スペイン、ロシア
・その他欧州
アジア太平洋
・日本、中国、韓国
・インド、オーストラリア
・その他アジア太平洋
中南米
・ブラジル、アルゼンチン
・その他中南米
中東アフリカ
・サウジアラビア、南アフリカ、UAE
・その他中東アフリカ
※地域別に全セグメント別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス(ドライバー、障壁、機会、課題)
・バリューチェーン分析
・ファイブフォース分析
・技術分析
・エコシステムマッピング
・特許分析
・ケーススタディ分析
・市場シェア分析
・競合状況
◆医薬品容器包装の主要企業プロフィール動向
・BERRY GLOBAL INC.
・GERRESHEIMER AG
・AMCOR PLC
・SCHOTT AG
・APTARGROUP, INC.
・BECTON, DICKINSON AND COMPANY
・WESTROCK COMPANY
・ニプロ株式会社
・CATALENT, INC.
・SEALED AIR
・WEST PHARMACEUTICAL SERVICES, INC.
（その他企業）
・ALPLA WERKE ALWIN LEHNER GMBH & CO KG
・ARDAGH GROUP S.A.
・CCL INDUSTRIES INC.
・FRANK NOE EGYPT LTD.
・GAPLAST GMBH
・LONZA GROUP LTD.
・MONDI GROUP
・NOLATO AB
・ORIGIN PHARMA PACKAGING
・COMAR
・BILCARE LIMITED
・SGD PHARMA
・SILGAN HOLDINGS INC.
・VETTER PHARMA INTERNATIONAL GMBH
（全315頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
・ FIGURE 1 PHARMACEUTICAL PACKAGING MARKET SEGMENTATION
1.3.1 REGIONS COVERED 39
1.3.2 YEARS CONSIDERED 40
1.4 CURRENCY CONSIDERED
1.5 UNIT CONSIDERED
1.6 STAKEHOLDERS
1.7 INCLUSIONS & EXCLUSIONS
・ TABLE 1 PHARMACEUTICAL PACKAGING MARKET: INCLUSIONS & EXCLUSIONS
1.8 SUMMARY OF CHANGES
1.9 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 IMPACT OF RECESSION
2.2 RESEARCH DATA
・ FIGURE 2 PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 MAJOR SECONDARY SOURCES
2.2.1.2 KEY DATA FROM SECONDARY SOURCES
2.2.2 PRIMARY DATA
2.2.3 PRIMARY INTERVIEWS
2.2.3.1 DEMAND AND SUPPLY SIDES
2.2.3.2 KEY DATA FROM PRIMARY SOURCES
2.2.3.3 KEY INDUSTRY INSIGHTS
2.2.3.4 BREAKDOWN OF PRIMARY INTERVIEWS
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
・ FIGURE 3 PHARMACEUTICAL PACKAGING MARKET: BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH 49
・ FIGURE 4 PHARMACEUTICAL PACKAGING MARKET: TOP-DOWN APPROACH
2.4 DATA TRIANGULATION
・ FIGURE 5 PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION
2.4.1 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH PRIMARY INTERVIEWS
2.4.2 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH SECONDARY SOURCES
・ FIGURE 6 PHARMACEUTICAL PACKAGING MARKET ANALYSIS
2.5 RESEARCH LIMITATIONS
2.6 RESEARCH ASSUMPTIONS
2.7 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
2.7.1 SUPPLY SIDE
2.7.2 DEMAND SIDE
2.7.3 INSIGHTS FROM KEY RESPONDENTS
2.8 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
・ FIGURE 7 PLASTIC BOTTLES TO BE LARGEST TYPE OF PHARMACEUTICAL PACKAGING
・ FIGURE 8 PLASTICS TO BE LARGEST RAW MATERIAL FOR PHARMACEUTICAL PACKAGING
・ FIGURE 9 ORAL DRUG DELIVERY MODE TO BE LARGEST SEGMENT OF PHARMACEUTICAL PACKAGING MARKET
・ FIGURE 10 ASIA PACIFIC TO BE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET
4 PREMIUM INSIGHTS
4.1 EMERGING ECONOMIES TO WITNESS HIGH GROWTH DURING FORECAST PERIOD
・ FIGURE 11 ASIA PACIFIC TO OFFER ATTRACTIVE OPPORTUNITIES IN PHARMACEUTICAL PACKAGING MARKET
4.2 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
・ FIGURE 12 PLASTIC BOTTLES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
4.3 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
・ FIGURE 13 PLASTICS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
4.4 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE
・ FIGURE 14 ORAL DRUG DELIVERY MODE TO LEAD MARKET BY 2027
4.5 GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY
・ FIGURE 15 MARKET IN INDIA TO GROW AT HIGHEST CAGR
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL PACKAGING MARKET
5.2.1 DRIVERS
5.2.1.1 GROWING HEALTHCARE EXPENDITURE AND PHARMACEUTICAL INDUSTRY IN EMERGING ECONOMIES
5.2.1.2 RISING DEMAND FOR DRUG DELIVERY DEVICES AND BLISTER PACKAGING 65
5.2.1.3 TECHNOLOGICAL ADVANCEMENTS
5.2.1.3.1 NANOMEDICINE AND NANO DRUG DELIVERY SYSTEMS (NDDS)
5.2.1.3.2 CHILD-RESISTANT PACKAGING (CRP)
5.2.1.3.3 RADIO-FREQUENCY IDENTIFICATION (RFID)
5.2.1.3.4 MICROPUMP TECHNOLOGY
5.2.1.3.5 ECO-FRIENDLY AND SUSTAINABLE PACKAGING
5.2.2 RESTRAINTS
5.2.2.1 INCREASING OVERALL PACKAGING COSTS DUE TO DYNAMIC REGULATORY POLICIES
5.2.2.2 LACK OF ACCESS TO PROPER HEALTHCARE IN EMERGING ECONOMIES
5.2.3 OPPORTUNITIES
5.2.3.1 GROWING DEMAND FOR PRIMARY PHARMACEUTICAL PACKAGING
5.2.4 CHALLENGES
5.2.4.1 SAFEGUARDING AGAINST COUNTERFEIT PRODUCTS
5.3 VALUE CHAIN ANALYSIS
・ FIGURE 17 PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS
5.3.1 RAW MATERIAL SUPPLIERS
5.3.2 R&D OF PRODUCTS
5.3.3 MANUFACTURERS
5.3.4 DISTRIBUTORS
5.3.5 END USERS
・ TABLE 2 PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN STAKEHOLDERS
5.4 PORTER'S FIVE FORCES ANALYSIS
・ FIGURE 18 PORTER'S FIVE FORCES ANALYSIS: PHARMACEUTICAL PACKAGING MARKET
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF BUYERS
5.4.4 BARGAINING POWER OF SUPPLIERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
・ TABLE 3 IMPACT OF PORTER'S FIVE FORCES ON PHARMACEUTICAL PACKAGING MARKET
5.5 MACROECONOMIC INDICATORS
5.5.1 GLOBAL GDP TRENDS 75
・ TABLE 4 TRENDS OF PER CAPITA GDP (USD) 2019–2021
・ TABLE 5 GDP GROWTH ESTIMATE AND PROJECTION OF KEY COUNTRIES, 2022–2027
・ TABLE 6 CURRENT HEALTH EXPENDITURE (% OF GDP) OF KEY COUNTRIES, 2018–2019
5.6 REGULATORY LANDSCAPE
5.6.1 REGULATIONS
5.6.1.1 EUROPE
5.6.1.2 US
5.6.1.3 OTHERS
5.7 TECHNOLOGY ANALYSIS
5.7.1 NANOTECHNOLOGY
5.7.2 PACKAGING FOR BIOLOGICS
5.7.3 SMART PACKAGING 79
5.7.4 ANTI-COUNTERFEIT PACKAGING
5.7.5 OTHER SMART TRENDS AND TECHNOLOGIES
5.8 PRICING ANALYSIS
5.8.1 AVERAGE SELLING PRICE, BY REGION
・ FIGURE 19 AVERAGE SELLING PRICE, BY REGION (USD/KG)
5.8.2 AVERAGE SELLING PRICE, BY RAW MATERIAL
・ TABLE 7 AVERAGE SELLING PRICE, BY RAW MATERIAL (USD/KG)
5.8.3 AVERAGE SELLING PRICE, BY COMPANY
・ TABLE 8 AVERAGE SELLING PRICE, BY COMPANY (USD/KG)
5.9 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING
・ FIGURE 20 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING
5.10 IMPACT OF COVID-19 ON PHARMACEUTICAL PACKAGING MARKET
5.10.1 IMPACT ON HEALTHCARE INDUSTRY
5.11 IMPACT OF RECESSION ON PHARMACEUTICAL PACKAGING MARKET
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
・ FIGURE 21 SUSTAINABLE PACKAGING, IOT, AND NANOTECHNOLOGY TO DRIVE GROWTH
5.13 PATENT ANALYSIS
5.13.1 INTRODUCTION
5.13.2 METHODOLOGY
5.13.3 DOCUMENT TYPE
・ FIGURE 22 PATENTS REGISTERED (2011–2021)
5.13.4 PUBLICATION TRENDS – LAST 10 YEARS
・ FIGURE 23 NUMBER OF PATENTS IN LAST 10 YEARS, 2011–2021
5.13.5 INSIGHTS
5.13.6 JURISDICTION ANALYSIS
・ FIGURE 24 TOP JURISDICTIONS 86
5.13.7 TOP PATENT APPLICANTS
・ FIGURE 25 TOP 10 PATENT APPLICANTS
・ TABLE 9 LIST OF PATENTS BY SANOFI AVENTIS DEUTSCHLAND
・ TABLE 10 LIST OF PATENTS BY SCHOTT AG
・ TABLE 11 LIST OF PATENTS BY TERUMO CORP
・ TABLE 12 LIST OF PATENTS BY BECTON DICKINSON AND COMPANY
・ TABLE 13 TOP 10 PATENT OWNERS (US) IN LAST 10 YEARS
5.14 RAW MATERIAL ANALYSIS
5.14.1 PLASTICS
5.14.2 PAPER
5.14.3 GLASS
5.14.4 METALS
5.15 TRADE ANALYSIS
5.16 OPERATIONAL DATA
5.17 KEY CONFERENCES AND EVENTS (2022–2023)
・ TABLE 14 KEY CONFERENCES AND EVENTS (2022–2023)
5.18 CASE STUDY ANALYSIS
5.18.1 MOISTURE BARRIER TECHNOLOGY FOR BETTER DRUG DELIVERY
5.18.2 CUSTOM TECHNOLOGY FOR BETTER BREATHING
6 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
6.1 INTRODUCTION
・ FIGURE 26 PLASTICS SEGMENT TO DOMINATE PHARMACEUTICAL PACKAGING MARKET
・ TABLE 15 BASIC PACKAGING RAW MATERIALS USED IN PHARMACEUTICAL PACKAGING
・ TABLE 16 RAW MATERIAL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 17 RAW MATERIAL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
・ TABLE 18 RAW MATERIAL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON)
・ TABLE 19 RAW MATERIAL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON)
・ TABLE 20 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION)
・ TABLE 21 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION)
・ TABLE 22 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON)
・ TABLE 23 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON)
6.2 PLASTICS
6.2.1 EXCELLENT SHATTER RESISTANCE OF PLASTICS TO BOOST ITS USE IN PRIMARY PACKAGING
・ TABLE 24 PLASTICS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 25 PLASTICS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
・ TABLE 26 PLASTICS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON)
・ TABLE 27 PLASTICS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON)
6.2.2 HIGH-DENSITY POLYETHYLENE (HDPE)
6.2.3 POLYESTER
6.2.4 POLYPROPYLENE (PP)
6.2.5 LOW-DENSITY POLYETHYLENE (LDPE)
6.2.6 POLYVINYL CHLORIDE (PVC)
6.2.7 CYCLIC OLEFIN COPOLYMER (COC)
6.2.8 POLYETHYLENE TEREPHTHALATE (PET)
6.3 PAPER & PAPERBOARD
6.3.1 INNOVATIONS IN SECONDARY PACKAGING TO PROPEL USE OF PAPER & PAPERBOARD
・ TABLE 28 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 29 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
・ TABLE 30 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON)
・ TABLE 31 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON)
6.4 GLASS
6.4.1 EXCELLENT CHEMICAL RESISTANCE OF GLASS TO BOOST ITS USE IN PRIMARY PACKAGING
・ TABLE 32 GLASS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 33 GLASS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
・ TABLE 34 GLASS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON)
・ TABLE 35 GLASS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON)
・ TABLE 36 TYPES OF GLASS USED FOR DIFFERENT PACKAGING
6.5 METALS
6.5.1 INCREASING USE OF ALUMINUM FOR BLISTER PACKAGING TO BOOST MARKET
・ TABLE 37 METALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 38 METALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
・ TABLE 39 METALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON)
・ TABLE 40 METALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON)
6.6 OTHERS
・ TABLE 41 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 42 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
・ TABLE 43 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON)
・ TABLE 44 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON)
7 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
7.1 INTRODUCTION
・ FIGURE 27 PLASTIC BOTTLES ACCOUNTED FOR LARGEST SHARE OF PHARMACEUTICAL PACKAGING MARKET
・ TABLE 45 PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 46 PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
・ TABLE 47 PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION)
・ TABLE 48 PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION)
7.2 PLASTIC BOTTLES
7.2.1 EASY OPERABILITY, SHATTER RESISTANCE, AND LIGHTWEIGHT PROPERTIES TO DRIVE DEMAND
・ TABLE 49 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 50 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
7.2.2 STANDARD PLASTIC BOTTLES
7.2.3 PLASTIC DISPENSING BOTTLES
7.2.4 PLASTIC JARS
7.3 BLISTER PACKS
7.3.1 EFFECTIVE DRUG PROTECTION AND EASY MANUFACTURING TO DRIVE MARKET
・ TABLE 51 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 52 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
7.3.2 COMPARTMENT PACKS 120
7.3.3 WALLET PACKS
7.4 LABELS & ACCESSORIES
7.4.1 PATIENT-DRUG COMMUNICATION COMPLIANCE TO BOOST DEMAND
・ TABLE 53 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 54 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
7.4.2 SELF-ADHESIVE LABELS
7.4.3 DIE-CUT LABELS
7.4.4 TAMPER-PROOF LABELS
7.4.5 HOLOGRAPHIC STRIP LABELS
7.5 CAPS & CLOSURES
7.5.1 DEMAND FOR TAMPER-EVIDENT PACKAGING TO PROPEL MARKET
・ TABLE 55 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 56 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
7.6 MEDICAL SPECIALTY BAGS
7.6.1 EASY HANDLING AND DISPOSABLE CHARACTERISTICS TO FUEL DEMAND
・ TABLE 57 MEDICAL SPECIALTY BAGS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 58 MEDICAL SPECIALTY BAGS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
7.7 PREFILLED SYRINGES
7.7.1 SELF-MEDICATION AND INCREASING CHRONIC DISEASES TO DRIVE DEMAND
・ TABLE 59 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 60 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
7.8 TEMPERATURE-CONTROLLED PACKAGING
7.8.1 INCREASING MANUFACTURING OF SPECIALIZED DRUGS TO FUEL MARKET
・ TABLE 61 TEMPERATURE-CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 62 TEMPERATURE CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
7.9 POUCHES & STRIP PACKS
7.9.1 INCREASING DEMAND FOR STANDUP POUCHES TO OFFER GROWTH OPPORTUNITIES
・ TABLE 63 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 64 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
7.10 AMPOULES
7.10.1 INCREASING DEMAND FROM DEVELOPING COUNTRIES TO DRIVE MARKET
・ TABLE 65 AMPOULES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 66 AMPOULES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
7.11 VIALS
7.11.1 DEMAND FOR VIALS IN VACCINE PACKAGING TO SUPPORT MARKET GROWTH
・ TABLE 67 VIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 68 VIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
7.12 PREFILLED INHALERS
7.12.1 INCREASING CASES OF PULMONARY DISEASES TO DRIVE DEMAND
・ TABLE 69 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET SIZE,
BY REGION, 2018–2021 (USD MILLION)
・ TABLE 70 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
7.12.2 METERED DOSE INHALERS
7.12.3 DRY POWDER INHALERS
7.13 MEDICATION TUBES
7.13.1 EASE OF USE TO INCREASE DEMAND
・ TABLE 71 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 72 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
7.13.2 COMPOSITE TUBES 132
7.13.3 ALL-PLASTIC TUBES 132
7.13.4 COLLAPSIBLE METAL TUBES
7.14 JARS & CANISTERS
7.14.1 EFFECTIVE BARRIER PROPERTIES TO PROPEL DEMAND
・ TABLE 73 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 74 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
7.15 CARTRIDGES
7.15.1 COMPATIBILITY WITH A VARIETY OF DEVICES TO DRIVE MARKET
・ TABLE 75 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 76 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
7.16 OTHERS
・ TABLE 77 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 78 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
8 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE
8.1 INTRODUCTION
・ FIGURE 28 ORAL DRUG DELIVERY MODE TO BE LARGEST SEGMENT IN 2022
・ TABLE 79 DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 80 DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
・ TABLE 81 PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2018–2021 (USD MILLION)
・ TABLE 82 PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2022–2027 (USD MILLION)
8.2 ORAL DRUG DELIVERY MODE
8.2.1 HIGH DEMAND FOR ORAL DRUG DELIVERY MODE OWING TO EASE OF USE
・ TABLE 83 ORAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 84 ORAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
8.3 INJEC・ TABLE DRUG DELIVERY MODE
8.3.1 HIGH BIOAVAILABILITY AND EFFICIENT TREATMENT TO BOOST THIS SEGMENT
・ TABLE 85 INJEC・ TABLE DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 86 INJEC・ TABLE DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
8.4 TOPICAL DRUG DELIVERY MODE
8.4.1 PREVALENCE OF SKIN DISEASES TO DRIVE MARKET FOR TOPICAL FORMULATIONS
・ TABLE 87 TOPICAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 88 TOPICAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
8.5 OCULAR/OPHTHALMIC DRUG DELIVERY MODE
8.5.1 INCREASING PREVALENCE OF EYE DISORDERS AND AGING POPULATION TO FUEL CONSUMPTION
・ TABLE 89 OCULAR/OPHTHALMIC DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 90 OCULAR/OPHTHALMIC DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
8.6 NASAL DRUG DELIVERY MODE
8.6.1 RAPID ABSORPTION AND FASTER ONSET OF ACTION TO PROPEL MARKET
・ TABLE 91 NASAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 92 NASAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
8.7 PULMONARY DRUG DELIVERY MODE
8.7.1 INCREASING CASES OF LUNG-RELATED DISEASES TO BOOST DEMAND
・ TABLE 93 PULMONARY DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 94 PULMONARY DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
8.8 TRANSDERMAL DRUG DELIVERY MODE
8.8.1 INCREASING SMALL-DOSE DRUG USE TO FUEL MARKET
・ TABLE 95 TRANSDERMAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 96 TRANSDERMAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
8.9 IV DRUG DELIVERY MODE
8.9.1 IMPROVED PATIENT COMPLIANCE AND HIGH DRUG DOSE CAPABILITY TO DRIVE DEMAND
・ TABLE 97 IV DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 98 IV DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
8.10 OTHER DRUG DELIVERY MODES
・ TABLE 99 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 100 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
9 PHARMACEUTICAL PACKAGING MARKET, BY REGION
9.1 INTRODUCTION
・ FIGURE 29 PHARMACEUTICAL PACKAGING MARKET IN INDIA TO REGISTER HIGHEST CAGR
・ TABLE 101 PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 102 PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 RECESSION IMPACT 152
・ FIGURE 30 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
・ TABLE 103 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)
・ TABLE 104 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
・ TABLE 105 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 106 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
・ TABLE 107 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION) 155
・ TABLE 108 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION) 155
・ TABLE 109 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION)
・ TABLE 110 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION)
・ TABLE 111 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION)
・ TABLE 112 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION)
・ TABLE 113 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON)
・ TABLE 114 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON)
9.2.2 US
9.2.2.1 RAPID TECHNOLOGICAL ADVANCEMENTS
・ TABLE 115 US: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 116 US: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.2.3 CANADA
9.2.3.1 COMPETITIVE BUSINESS ENVIRONMENT TO BOOST MARKET
・ TABLE 117 CANADA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 118 CANADA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.2.4 MEXICO
9.2.4.1 GOVERNMENT INITIATIVES IN HEALTHCARE INDUSTRY TO FUEL DEMAND
・ TABLE 119 MEXICO: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 120 MEXICO: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.3 EUROPE
9.3.1 RECESSION IMPACT 165
・ TABLE 121 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)
・ TABLE 122 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
・ TABLE 123 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 124 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
・ TABLE 125 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION)
・ TABLE 126 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION)
・ TABLE 127 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION)
・ TABLE 128 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION)
・ TABLE 129 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION)
・ TABLE 130 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION)
・ TABLE 131 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON)
・ TABLE 132 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON)
9.3.2 GERMANY
9.3.2.1 INCREASE IN AGING POPULATION AND NON-COMMUNICABLE DISEASES TO DRIVE MARKET
・ TABLE 133 GERMANY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 134 GERMANY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 HIGH DEMAND FOR GENERIC DRUGS TO DRIVE MARKET
・ TABLE 135 FRANCE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 136 FRANCE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 GROWING EXPORTS OF PHARMACEUTICALS TO IMPACT MARKET GROWTH
・ TABLE 137 ITALY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 138 ITALY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.3.5 UK
9.3.5.1 INNOVATION IN DRUG MANUFACTURING TO INCREASE DEMAND
・ TABLE 139 UK: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 140 UK: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 GOVERNMENT INITIATIVES IN HEALTHCARE SECTOR TO BOOST DEMAND
・ TABLE 141 SPAIN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 142 SPAIN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.3.7 RUSSIA
9.3.7.1 GOVERNMENT INITIATIVES FOR DOMESTIC PRODUCTION OF PHARMACEUTICALS TO FUEL MARKET
・ TABLE 143 RUSSIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 144 RUSSIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.3.8 REST OF EUROPE
・ TABLE 145 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 146 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 RECESSION IMPACT 184
・ FIGURE 31 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
・ TABLE 147 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)
・ TABLE 148 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
・ TABLE 149 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 150 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
・ TABLE 151 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION) 188
・ TABLE 152 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION) 188
・ TABLE 153 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION)
・ TABLE 154 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION)
・ TABLE 155 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION)
・ TABLE 156 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION)
・ TABLE 157 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON)
・ TABLE 158 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON)
9.4.2 CHINA
9.4.2.1 INCREASED INVESTMENTS IN R&D OF BIOLOGICS AND BIOSIMILAR DRUGS TO DRIVE MARKET
・ TABLE 159 CHINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 160 CHINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.4.3 JAPAN
9.4.3.1 SIZEABLE AGING POPULATION TO DRIVE DEMAND FOR MEDICATIONS
・ TABLE 161 JAPAN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 162 JAPAN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.4.4 SOUTH KOREA
9.4.4.1 WELL-DEVELOPED HEALTHCARE INDUSTRY AND PRESENCE OF MAJOR PHARMACEUTICALS MANUFACTURERS TO DRIVE MARKET
・ TABLE 163 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 164 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.4.5 INDIA
9.4.5.1 LARGE DOMESTIC CONSUMPTION AND EXPORT OF GENERIC DRUGS TO DRIVE MARKET
・ TABLE 165 INDIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 166 INDIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.4.6 AUSTRALIA
9.4.6.1 MEDICARE AND PBS SCHEMES STRENGTHENING COUNTRY’S PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
・ TABLE 167 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 168 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.4.7 REST OF ASIA PACIFIC
・ TABLE 169 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 203
・ TABLE 170 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.5 SOUTH AMERICA
9.5.1 RECESSION IMPACT 205
・ TABLE 171 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)
・ TABLE 172 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
・ TABLE 173 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 174 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
・ TABLE 175 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION) 207
・ TABLE 176 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION) 207
・ TABLE 177 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION)
・ TABLE 178 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION)
・ TABLE 179 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION)
・ TABLE 180 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION)
・ TABLE 181 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON)
・ TABLE 182 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON)
9.5.2 BRAZIL
9.5.2.1 FREE AND UNIVERSAL HEALTHCARE SERVICES TO SUPPORT GROWTH OF PHARMACEUTICAL INDUSTRY
・ TABLE 183 BRAZIL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 184 BRAZIL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.5.3 ARGENTINA
9.5.3.1 PLASTIC BOTTLES TO ACCOUNT FOR LARGEST MARKET SHARE
・ TABLE 185 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 186 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.5.4 REST OF SOUTH AMERICA
・ TABLE 187 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 215
・ TABLE 188 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 216
9.6 MIDDLE EAST & AFRICA
9.6.1 RECESSION IMPACT 217
・ TABLE 189 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)
・ TABLE 190 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
・ TABLE 191 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 218
・ TABLE 192 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 219
・ TABLE 193 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION)
・ TABLE 194 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION)
・ TABLE 195 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION)
・ TABLE 196 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION)
・ TABLE 197 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION)
・ TABLE 198 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION)
・ TABLE 199 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON)
・ TABLE 200 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON)
9.6.2 SAUDI ARABIA
9.6.2.1 WIDER ACCESS TO HEALTHCARE SERVICES TO INCREASE DEMAND FOR PHARMACEUTICALS
・ TABLE 201 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 202 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.6.3 SOUTH AFRICA
9.6.3.1 GRADUAL RISE IN GENERIC DRUG USE TO FUEL PHARMACEUTICAL PACKAGING MARKET
・ TABLE 203 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 204 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.6.4 UAE
9.6.4.1 INCREASING INITIATIVES FOR DOMESTIC PHARMACEUTICAL PRODUCTION TO DRIVE MARKET
・ TABLE 205 UAE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 206 UAE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
9.6.5 REST OF MIDDLE EAST & AFRICA
・ TABLE 207 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 208 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
・ FIGURE 32 COMPANIES ADOPTED INVESTMENT & EXPANSION AND NEW PRODUCT DEVELOPMENT AS KEY GROWTH STRATEGIES
10.3 MARKET EVALUATION MATRIX
・ TABLE 209 MARKET EVALUATION MATRIX
10.4 REVENUE ANALYSIS
・ TABLE 210 REVENUE OF KEY COMPANIES IN LAST THREE YEARS
10.5 RANKING ANALYSIS OF KEY MARKET PLAYERS, 2021
・ FIGURE 33 RANKING OF TOP 5 PLAYERS IN PHARMACEUTICAL PACKAGING MARKET, 2021
10.5.1 BERRY GLOBAL INC. 235
10.5.2 AMCOR PLC
10.5.3 APTARGROUP, INC. 235
10.5.4 GERRESHEIMER AG 236
10.5.5 SCHOTT AG
10.6 MARKET SHARE ANALYSIS
・ FIGURE 34 PHARMACEUTICAL PACKAGING MARKET SHARE, BY COMPANY (2021)
・ TABLE 211 PHARMACEUTICAL PACKAGING MARKET: DEGREE OF COMPETITION
10.7 COMPANY EVALUATION MATRIX (TIER 1)
10.7.1 STARS
10.7.2 PERVASIVE PLAYERS 237
10.7.3 EMERGING LEADERS 237
10.7.4 PARTICIPANTS
・ FIGURE 35 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX FOR TIER 1 COMPANIES, 2021
10.8 STRENGTH OF PRODUCT PORTFOLIO
10.9 BUSINESS STRATEGY EXCELLENCE
10.10 COMPANY EVALUATION MATRIX (START-UPS AND SMES)
10.10.1 PROGRESSIVE COMPANIES
10.10.2 RESPONSIVE COMPANIES
10.10.3 STARTING BLOCKS 240
10.10.4 DYNAMIC COMPANIES 240
・ FIGURE 36 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS AND SMES, 2021
10.11 STRENGTH OF PRODUCT PORTFOLIO (START-UPS AND SMES)
10.12 BUSINESS STRATEGY EXCELLENCE (START-UPS AND SMES)
10.13 COMPETITIVE BENCHMARKING
・ TABLE 212 PHARMACEUTICAL PACKAGING MARKET: DETAILED LIST OF COMPANIES
10.13.1 COMPANY DRUG DELIVERY MODE FOOTPRINT
・ TABLE 213 OVERALL DRUG DELIVERY MODE FOOTPRINT
10.13.2 COMPANY TYPE FOOTPRINT
・ TABLE 214 OVERALL TYPE FOOTPRINT
10.13.3 COMPANY REGION FOOTPRINT
・ TABLE 215 OVERALL REGION FOOTPRINT
10.13.4 COMPANY FOOTPRINT 249
・ TABLE 216 OVERALL COMPANY FOOTPRINT
10.14 COMPETITIVE SITUATION AND TRENDS
10.14.1 PRODUCT LAUNCHES 250
・ TABLE 217 PHARMACEUTICAL PACKAGING: PRODUCT LAUNCHES, 2018–NOVEMBER 2022
10.14.2 DEALS
・ TABLE 218 PHARMACEUTICAL PACKAGING: DEALS, 2018–NOVEMBER 2022
10.14.3 OTHERS
・ TABLE 219 PHARMACEUTICAL PACKAGING MARKET: OTHERS, 2018–NOVEMBER 2022
11 COMPANY PROFILES
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
11.1 BERRY GLOBAL INC.
・ TABLE 220 BERRY GLOBAL: COMPANY OVERVIEW
・ FIGURE 37 BERRY GLOBAL: COMPANY SNAPSHOT
・ TABLE 221 BERRY GLOBAL: PRODUCTS OFFERED
・ TABLE 222 BERRY GLOBAL: PRODUCT LAUNCHES
・ TABLE 223 BERRY GLOBAL: DEALS
・ TABLE 224 BERRY GLOBAL: OTHER DEVELOPMENTS
11.2 GERRESHEIMER AG
・ TABLE 225 GERRESHEIMER AG: COMPANY OVERVIEW
・ FIGURE 38 GERRESHEIMER AG: COMPANY SNAPSHOT
・ TABLE 226 GERRESHEIMER AG: PRODUCTS OFFERED
・ TABLE 227 GERRESHEIMER AG: PRODUCT LAUNCHES
・ TABLE 228 GERRESHEIMER AG: OTHER DEVELOPMENTS
11.3 AMCOR PLC
・ TABLE 229 AMCOR PLC: COMPANY OVERVIEW
・ FIGURE 39 AMCOR: COMPANY SNAPSHOT
・ TABLE 230 AMCOR: PRODUCTS OFFERED
・ TABLE 231 AMCOR: PRODUCT LAUNCHES
・ TABLE 232 AMCOR: DEALS
・ TABLE 233 AMCOR: OTHER DEVELOPMENTS
11.4 SCHOTT AG
・ TABLE 234 SCHOTT AG: COMPANY OVERVIEW
・ FIGURE 40 SCHOTT AG: COMPANY SNAPSHOT
・ TABLE 235 SCHOTT AG: PRODUCTS OFFERED
・ TABLE 236 SCHOTT AG: PRODUCT LAUNCHES
・ TABLE 237 SCHOTT AG: DEALS 279
・ TABLE 238 SCHOTT AG: OTHER DEVELOPMENTS
11.5 APTARGROUP, INC.
・ TABLE 239 APTARGROUP, INC.: COMPANY OVERVIEW
・ FIGURE 41 APTARGROUP: COMPANY SNAPSHOT
・ TABLE 240 APTARGROUP: PRODUCTS OFFERED
・ TABLE 241 APTARGROUP: PRODUCT LAUNCHES
・ TABLE 242 APTARGROUP: DEALS 285
・ TABLE 243 APTARGROUP: OTHER DEVELOPMENTS
11.6 BECTON, DICKINSON AND COMPANY
・ TABLE 244 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
・ FIGURE 42 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
・ TABLE 245 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
・ TABLE 246 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES
・ TABLE 247 BECTON, DICKINSON AND COMPANY: DEALS
・ TABLE 248 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS
11.7 WESTROCK COMPANY
・ TABLE 249 WESTROCK COMPANY: COMPANY OVERVIEW
・ FIGURE 43 WESTROCK COMPANY: COMPANY SNAPSHOT
・ TABLE 250 WESTROCK COMPANY: PRODUCTS OFFERED
・ TABLE 251 WESTROCK COMPANY: OTHER DEVELOPMENTS
11.8 NIPRO CORPORATION
・ TABLE 252 NIPRO CORPORATION: COMPANY OVERVIEW
・ FIGURE 44 NIPRO CORPORATION: COMPANY SNAPSHOT
・ TABLE 253 NIPRO CORPORATION: PRODUCTS OFFERED
・ TABLE 254 NIPRO CORPORATION: DEALS
11.9 CATALENT, INC.
・ TABLE 255 CATALENT, INC.: COMPANY OVERVIEW
・ FIGURE 45 CATALENT: COMPANY SNAPSHOT
・ TABLE 256 CATALENT: PRODUCTS OFFERED
・ TABLE 257 CATALENT: DEALS 296
・ TABLE 258 CATALENT: OTHER DEVELOPMENTS
11.10 SEALED AIR
・ TABLE 259 SEALED AIR: COMPANY OVERVIEW
・ FIGURE 46 SEALED AIR: COMPANY SNAPSHOT
・ TABLE 260 SEALED AIR: PRODUCTS OFFERED
・ TABLE 261 SEALED AIR: PRODUCT LAUNCHES
・ TABLE 262 SEALED AIR: DEALS 300
11.11 WEST PHARMACEUTICAL SERVICES, INC.
・ TABLE 263 WEST PHARMACEUTICAL SERVICES: COMPANY OVERVIEW
・ FIGURE 47 WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT
・ TABLE 264 WEST PHARMACEUTICAL SERVICES: PRODUCTS OFFERED
・ TABLE 265 WEST PHARMACEUTICAL SERVICES: PRODUCT LAUNCHES
・ TABLE 266 WEST PHARMACEUTICAL SERVICES: OTHER DEVELOPMENTS
11.12 OTHERS
11.12.1 ALPLA WERKE ALWIN LEHNER GMBH & CO KG
・ TABLE 267 ALPLA WERKE ALWIN LEHNER GMBH & CO KG: COMPANY OVERVIEW
11.12.2 ARDAGH GROUP S.A. 305
・ TABLE 268 ARDAGH GROUP S.A.: COMPANY OVERVIEW
11.12.3 CCL INDUSTRIES INC.
・ TABLE 269 CCL INDUSTRIES INC.: COMPANY OVERVIEW
11.12.4 FRANK NOE EGYPT LTD.
・ TABLE 270 FRANK NOE EGYPT LTD.: COMPANY OVERVIEW
11.12.5 GAPLAST GMBH
・ TABLE 271 GAPLAST GMBH: COMPANY OVERVIEW
11.12.6 LONZA GROUP LTD. 309
・ TABLE 272 LONZA GROUP LTD.: COMPANY OVERVIEW
11.12.7 MONDI GROUP
・ TABLE 273 MONDI GROUP: COMPANY OVERVIEW
11.12.8 NOLATO AB
・ TABLE 274 NOLATO AB: COMPANY OVERVIEW
11.12.9 ORIGIN PHARMA PACKAGING
・ TABLE 275 ORIGIN PHARMA PACKAGING: COMPANY OVERVIEW
11.12.10 COMAR
・ TABLE 276 COMAR: COMPANY OVERVIEW
11.12.11 BILCARE LIMITED 314
・ TABLE 277 BILCARE LIMITED: COMPANY OVERVIEW
11.12.12 SGD PHARMA
・ TABLE 278 SGD PHARMA: COMPANY OVERVIEW
11.12.13 SILGAN HOLDINGS INC.
・ TABLE 279 SILGAN HOLDINGS INC.: COMPANY OVERVIEW
11.12.14 VETTER PHARMA INTERNATIONAL GMBH
・ TABLE 280 VETTER PHARMA INTERNATIONAL GMBH: COMPANY OVERVIEW
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS